Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia
2021
68 citations
Journal Article
gold Open Access
Field-Weighted Citation Impact:
4.47
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia | Researchclopedia
·
Hubei Provincial Center for Disease Control and Prevention
Jue Wang
·
Hubei Provincial Center for Disease Control and Prevention
Lijun Jiang
·
Hubei Provincial Center for Disease Control and Prevention
Hao Xu
·
Hubei Provincial Center for Disease Control and Prevention
Jinhuan Xu
·
Hubei Provincial Center for Disease Control and Prevention
Xiaoxi Zhou
·
Hubei Provincial Center for Disease Control and Prevention
Zhenya Hong
·
Hubei Provincial Center for Disease Control and Prevention
Na Wang
·
Hubei Provincial Center for Disease Control and Prevention
Liang Huang
·
Hubei Provincial Center for Disease Control and Prevention
Shangkun Zhang
·
Wuhan Institute of Bioengineering
Liting Chen
·
Hubei Provincial Center for Disease Control and Prevention
Xia Mao
·
Hubei Provincial Center for Disease Control and Prevention
Min Xiao
·
Hubei Provincial Center for Disease Control and Prevention
Wei Zhang
·
Hubei Provincial Center for Disease Control and Prevention
Meng Li
·
Hubei Provincial Center for Disease Control and Prevention
Yang Cao
·
Hubei Provincial Center for Disease Control and Prevention
Tongcun Zhang
·
Wuhan Institute of Bioengineering
Li J
·
Chinese Academy of Medical Sciences & Peking Union Medical College
Jianfeng Zhou
·
Hubei Provincial Center for Disease Control and Prevention